bitbio
bit.bio is a pioneering biotechnology company specializing in cell programming technology. The company focuses on developing and commercializing advanced solutions that enable precise control over cell identity, with applications in research, drug discovery, and regenerative medicine.
Leadership & Board
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $80M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $50M
- Latest Funding Round
- Series C
- Post-Money Valuation
- ―
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 09, 2026 | Series C | $50.00M | ― |
| Aug 14, 2025 | Investment | $30.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| M&G Investments | Series C |
| Tencent | Investment |
| M&G Investments | Investment |
| ARCH Venture Partners | Investment |
| BlueYard Capital | Investment |
| Milky Way | Investment |
| Puhua Capital | Investment |
Similar Companies
A snapshot of private companies similar to bitbio, helping you discover and navigate related company profiles.
Related News and Analysis
